<SEC-DOCUMENT>0001209191-23-035616-index.html : 20230608
<SEC-HEADER>0001209191-23-035616.hdr.sgml : 20230608
<ACCEPTANCE-DATETIME>20230608213435
ACCESSION NUMBER:		0001209191-23-035616
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230606
FILED AS OF DATE:		20230608
DATE AS OF CHANGE:		20230608

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Knobil Katharine
		CENTRAL INDEX KEY:			0001768011

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37939
		FILM NUMBER:		231003691

	MAIL ADDRESS:	
		STREET 1:		C/O KALEIDO BIOSCIENCES, INC.
		STREET 2:		65 HAYDEN AVE.
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Marker Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001094038
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880277072
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		4551 KENNEDY COMMERCE DR.
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77032
		BUSINESS PHONE:		(713) 400-6400

	MAIL ADDRESS:	
		STREET 1:		4551 KENNEDY COMMERCE DR.
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77032

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TAPIMMUNE INC.
		DATE OF NAME CHANGE:	20170629

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TAPIMMUNE INC
		DATE OF NAME CHANGE:	20070628

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENEMAX CORP
		DATE OF NAME CHANGE:	20020718
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>